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  Prior	  studies	  suggest	  a	  high	  prevalence	  of	  depression	  in	  patients	  with	  chest	  pain,	  but	  few	  US	  studies	  have	  examined	  depression	  and	  recurrent	  chest	  pain	  in	  the	  emergency	  room	  setting.	  This	  study	  sought	  to	  compare	  symptoms	  of	  depression,	  socio-­‐demographic	  features,	  and	  clinical	  features	  between	  low-­‐moderate-­‐risk	  emergency	  room	  (ER)	  chest	  pain	  center	  (CPC)	  patients	  with	  and	  without	  recurrent	  chest	  pain	  at	  one-­‐month	  following	  enrollment.	  
	  This	  study	  was	  a	  prospective	  cohort	  study	  using	  convenience	  sample	  at	  a	  tertiary	  care	  hospital	  emergency	  room	  in	  a	  semi-­‐urban	  setting.	  Patients	  were	  recruited	  from	  the	  chest	  pain	  center	  (CPC),	  and	  completed	  baseline	  surveys	  that	  assessed	  depression,	  anxiety,	  stress	  and	  chest	  pain.	  A	  one-­‐month	  follow-­‐up	  assessed	  the	  recurrence	  of	  chest	  pain.	  Univariate	  and	  multivariate	  statistical	  analyses	  were	  conducted.	  	  
	  Between	  July	  30th	  2013	  to	  January	  31st	  2015	  a	  total	  of	  850	  patients	  were	  invited	  to	  participate	  in	  our	  study,	  442	  (52.0%)	  agreed	  to	  do	  so,	  of	  which	  327	  (74.0%)	  were	  included	  in	  the	  final	  analysis.	  An	  overall	  29%	  had	  some	  evidence	  of	  depression,	  be	  it	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  There	  are	  more	  than	  8	  million	  annual	  visits	  to	  U.S.	  emergency	  rooms	  for	  chest	  pain.	  Each	  time	  the	  primary	  concern	  is	  for	  acute	  coronary	  syndrome	  (ACS),	  as	  it	  is	  the	  number	  one	  cause	  of	  death	  in	  the	  United	  States.	  The	  current	  standard	  of	  care	  is	  based	  on	  American	  Heart	  Association	  guidelines,	  and	  includes	  a	  focused	  history	  and	  physical	  exam,	  a	  12-­‐lead	  ECG,	  and	  serial	  laboratory	  studies	  for	  cardiac	  injury	  markers.1	  However,	  adverse	  cardiac	  events	  are	  identified	  in	  as	  few	  as	  15-­‐25%	  of	  patients,	  who	  are	  quickly	  routed	  down	  established	  pathways	  of	  cardio-­‐protective	  care.1,2	  Sadly,	  there	  are	  a	  reported	  2-­‐4%	  of	  major	  adverse	  cardiac	  events	  that	  are	  missed,	  with	  patients	  inappropriately	  discharged	  from	  the	  hospital.3	  Given	  the	  high	  mortality	  associated	  with	  these	  missed	  cases,	  and	  the	  threat	  of	  litigation,	  the	  standard	  of	  care	  is	  applied	  rigorously	  to	  patients	  seen	  in	  the	  emergency	  department,	  often	  leading	  to	  extensive	  work-­‐ups.	  Since	  the	  majority	  of	  patients	  will	  initially	  test	  negative,	  many	  emergency	  departments	  now	  have	  dedicated	  chest	  pain	  units	  (CPUs)	  for	  further	  observation	  of	  these	  patients.	  In	  these	  settings,	  patients	  are	  monitored,	  and	  serial	  cardiac	  enzymes	  and	  repeat	  ECGs	  are	  performed.	  After	  a	  minimum	  period	  of	  time,	  stress	  tests	  and/or	  imaging	  studies	  are	  performed	  to	  rule	  out	  ischemia.	  	  	  After	  testing	  fails	  to	  reveal	  ACS	  or	  underlying	  CAD,	  patients	  are	  often	  discharged	  with	  the	  ambiguous	  diagnosis	  of	  non-­‐cardiac	  chest	  pain	  (NCCP).	  This	  heterogeneous	  diagnosis	  includes	  causes	  such	  as	  gastro-­‐esophageal	  reflux	  disease,	  esophageal	  spasm,	  musculoskeletal	  pain,	  hyperventilation,	  general	  anxiety	  and	  panic	  disorder.	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In	  addition,	  there	  is	  growing	  evidence	  for	  unrecognized	  coronary	  artery	  disease	  (CAD)	  and	  microvascular	  dysfunction,	  as	  potential	  etiologies.	  Once	  a	  certain	  diagnostic	  rigor	  has	  failed	  to	  identify	  a	  cause,	  labels	  like	  nonobstructive,	  non-­‐specific,	  or	  unexplained	  chest	  pain	  may	  seem	  more	  appropriate.	  	  	  Interestingly,	  psychiatric	  factors	  could	  potentially	  cause	  or	  worsen	  chest	  pain	  in	  a	  variety	  of	  ways,	  and	  it	  can	  be	  unclear	  whether	  psychiatric	  symptoms	  arise	  from	  or	  produce	  some	  of	  the	  other	  causes	  of	  chest	  pain,	  such	  as	  hyperventilation,	  muscle	  spasm,	  and	  even	  microvascular	  disease.4	  Conversely,	  psychiatric	  conditions	  such	  as	  depression	  also	  increase	  cardiac	  mortality	  in	  patients.5	  Further	  complicating	  matters,	  psychiatric	  disease	  is	  often	  associated	  with	  non-­‐specific	  symptoms	  and	  co-­‐morbid	  risk	  factors,	  making	  its	  effects	  a	  challenge	  to	  track.	  This	  study	  seeks	  to	  explore	  the	  relationship	  between	  depression	  and	  chest	  pain	  in	  patients	  admitted	  to	  an	  emergency	  department	  CPU	  for	  cardiac	  observation.	  	  	  The	  aims	  of	  our	  study	  were	  as	  follows:	  	  
Primary	  Aim	  1:	  symptom	  burden	  of	  depression	  in	  a	  chest	  pain	  unit	  	  Psychiatric	  conditions	  have	  long	  been	  associated	  with	  chest	  pain,	  and	  this	  can	  be	  one	  of	  the	  first	  thoughts	  that	  comes	  to	  mind	  when	  someone	  with	  few	  risk	  factors	  experiences	  chest	  pain.	  For	  patients	  with	  chest	  pain,	  anxiety	  has	  received	  the	  most	  attention	  from	  the	  research	  and	  medical	  community.	  A	  large	  number	  of	  studies	  have	  been	  performed	  and	  agree	  that	  the	  prevalence	  of	  anxiety	  and	  panic	  disorders	  is	  high	  
	  	  
3	  
in	  chest	  pain	  populations,	  and	  particularly	  so	  for	  non-­‐cardiac	  chest	  pain	  compared	  to	  known-­‐cause	  chest	  pain.	  A	  recently	  published	  review	  of	  psychological	  outcomes	  in	  patients	  with	  non-­‐cardiac	  chest	  pain,	  reported	  the	  prevalence	  of	  anxiety	  to	  be	  between	  21	  and	  53.5%.6	  	  	  Less	  studied	  and	  less	  well	  understood	  is	  the	  relationship	  between	  depression	  and	  chest	  pain.	  Existing	  studies	  are	  limited	  and	  have	  produced	  inconsistent	  results	  when	  assessing	  depression	  in	  patients	  with	  non-­‐cardiac	  chest	  pain.6	  For	  example,	  comparisons	  of	  depression	  scores	  in	  patients	  with	  non-­‐coronary	  chest	  pain	  to	  patients	  with	  coronary	  chest	  pain,	  or	  to	  the	  general	  population,	  have	  produced	  somewhat	  mixed	  results.	  Some	  studies	  have	  reported	  levels	  of	  depression	  in	  non-­‐coronary	  chest	  pain	  patients	  to	  be	  similar	  to,	  or	  even	  lower	  than,	  levels	  seen	  in	  coronary	  chest	  pain	  patients,6-­‐9	  while	  other	  studies	  report	  the	  high	  levels	  of	  depression	  in	  non-­‐coronary	  chest	  pain	  patients.10,11.8	  Given	  the	  conflicting	  data,	  the	  foremost	  aim	  of	  our	  study	  is	  to	  describe	  the	  burden	  and	  severity	  of	  depressive	  symptoms	  in	  ED	  chest	  pain	  patients.	  We	  also	  wanted	  to	  examine	  the	  demographic,	  socio-­‐economic,	  and	  clinical	  patient	  profiles	  that	  are	  associated	  with	  depression	  in	  ED	  chest	  pain	  patients	  and	  understand	  its	  association	  with	  recurrent	  chest	  pain	  after	  discharge.	  Similar	  attempts	  in	  similar	  US	  settings	  are	  limited,	  and	  there	  is	  clinical	  and	  scientific	  benefit	  to	  replicating	  these	  inquiries	  at	  unique	  sites,	  as	  the	  present	  work	  intends	  to	  do.	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Primary	  Aim	  2:	  depression	  and	  recurrence/persistence	  of	  chest	  pain	  after	  ED	  
discharge	  The	  majority	  of	  studies	  evaluating	  depression	  in	  patients	  with	  new	  onset	  chest	  pain	  are	  cross-­‐sectional,	  and	  few	  U.S.	  based	  studies	  have	  captured	  future	  prognosis	  of	  these	  patients.	  This	  stands	  in	  contrast	  to	  research	  of	  coronary	  heart	  disease	  (CHD)	  and	  post-­‐myocardial	  infarct	  (post-­‐MI),	  wherein	  there	  is	  a	  preponderance	  of	  valuable	  prospective	  evidence	  linking	  depression	  to	  cardiac	  morbidity	  and	  mortality.5,12-­‐15	  However,	  some	  studies	  have	  taken	  the	  endeavor	  to	  follow	  low-­‐risk	  chest	  pain	  patients	  from	  the	  emergency	  department	  onwards.	  A	  recent	  UK	  publication	  found	  anxiety,	  depression	  and	  quality	  of	  life	  to	  be	  associated	  with	  higher	  frequency	  of	  persistent	  chest	  pain,	  but	  did	  not	  find	  high	  levels	  of	  depression	  in	  their	  studied	  population.16	  Our	  goal	  was	  to	  investigate	  whether	  similar	  relationship	  is	  seen	  in	  emergency	  department	  patients	  in	  the	  US.	  	  Previous	  studies	  have	  suggested	  that	  depression	  interacts	  with	  comorbid	  disease	  in	  a	  non-­‐homogeneous	  manner,	  meaning	  that	  only	  certain	  aspects	  of	  depression	  associate	  with	  clinical	  outcomes.17-­‐19	  Among	  CAD	  studies,	  there	  is	  evidence	  that	  somatic	  symptoms	  may	  be	  associated	  with	  worsened	  cardiac	  prognosis.	  18-­‐21	  Furthermore,	  the	  large	  NHLBI-­‐funded	  Women's	  Ischemia	  Syndrome	  Evaluation	  (WISE)	  study,	  found	  somatic	  (and	  not	  cognitive)	  symptoms	  to	  be	  associated	  with	  cardiovascular	  mortality	  and	  events	  in	  women.22	  Likewise,	  this	  study	  seeks	  to	  consider	  cognitive/somatic	  symptoms	  separately	  in	  a	  gender-­‐specific	  model,	  as	  potential	  correlates	  to	  recurrent/persistent	  chest	  pain.	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Secondary	  Aim	  1:	  depression	  and	  chest	  pain	  by	  gender	  The	  literature	  is	  mixed	  regarding	  the	  burden	  of	  depression	  for	  women	  and	  men	  with	  chest	  pain.	  In	  general,	  women	  are	  more	  likely	  to	  suffer	  from	  depression	  than	  men,	  but	  the	  implications	  for	  chest	  pain	  are	  unclear.	  Very	  few	  studies	  describing	  gender	  differences	  were	  based	  in	  the	  emergency	  setting.	  One	  such	  publication	  that	  considered	  risk	  factors	  for	  chest	  pain	  in	  men	  and	  women	  found	  an	  independent	  association	  between	  depression	  and	  chest	  pain,	  in	  the	  case	  of	  women	  only.23	  Yet	  another	  study,	  also	  a	  rare	  prospective	  investigation	  into	  recurrent	  chest	  pain,	  found	  no	  differences	  associated	  with	  gender.16	  More	  observational	  work	  is	  needed	  to	  clarify	  the	  conflicting	  relationship.	  Also,	  both	  of	  these	  conclusions	  were	  drawn	  outside	  the	  U.S.	  and	  may	  not	  be	  transferrable	  to	  our	  population.	  In	  contrast,	  a	  prior	  pilot	  study	  conducted	  in	  the	  same	  CPU	  setting	  as	  the	  present	  work	  found	  high	  levels	  of	  depression	  in	  women,	  encouraging	  further	  study,	  but	  drew	  no	  comparisons	  to	  men.4	  The	  paucity	  of	  evidence	  directly	  relating	  to	  this	  topic	  make	  it	  a	  goal	  of	  the	  present	  work	  to	  compare	  the	  effect	  of	  depression	  on	  recurrence	  of	  chest	  pain	  in	  both	  men	  and	  women.	  	  
	  Ultimately,	  this	  work	  seeks	  to	  cast	  some	  degree	  of	  illumination	  on	  the	  interaction	  between	  depressive	  symptoms	  and	  chest	  pain.	  For	  the	  sake	  of	  clarity,	  references	  to	  “chest	  pain”	  will	  signify	  undifferentiated	  chest	  pain	  with	  symptoms	  of	  discomfort	  similar-­‐in-­‐nature	  to	  those	  seen	  in	  coronary	  disease.	  The	  two	  primary	  aims	  of	  this	  work	  are	  as	  follows:	  1)	  to	  establish	  the	  prevalence	  and	  symptom	  burden	  of	  depression,	  and	  to	  examine	  what	  demographic,	  socio-­‐economic,	  and	  clinical	  patient	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  Overview	  We	  conducted	  a	  prospective	  cohort	  study	  using	  convenience	  sample	  at	  a	  tertiary	  care	  hospital	  emergency	  room	  in	  a	  semi-­‐urban	  setting.	  We	  obtained	  written	  informed	  consent	  from	  each	  patient	  prior	  to	  enrollment.	  The	  study	  was	  approved	  by	  the	  Yale	  Institutional	  Review	  Board.	  Baseline	  assessments	  were	  collected	  while	  the	  patient	  was	  admitted	  to	  the	  CPC.	  We	  interviewed	  patients	  to	  collect	  their	  socio-­‐demographic	  and	  behavioral	  data,	  clinical	  history	  and	  risk	  factors	  as	  well	  measurement	  of	  their	  pain,	  and	  psychological	  assessments	  using	  four	  validated	  questionnaires.	  We	  also	  collected	  locator	  information	  from	  them	  as	  well	  as	  the	  most	  convenient	  number	  and	  time	  to	  reach	  them	  for	  follow	  up.	  We	  conducted	  follow-­‐up	  interviews	  by	  telephone,	  one	  month	  following	  enrollment.	  Follow-­‐up	  inquiry	  began	  with	  a	  yes/no	  determination	  of	  recurrent	  chest	  pain,	  and	  if	  patients	  answered	  “yes”	  we	  assessed	  frequency	  of	  symptoms.	  Telephone	  calls	  were	  typically	  made	  in	  the	  early	  evenings,	  as	  most	  patients	  indicated	  this	  to	  be	  the	  most	  convenient	  time.	  If	  we	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were	  unable	  to	  reach	  patients	  after	  five	  telephone	  calls,	  we	  mailed	  reminders,	  and	  we	  continued	  with	  five	  additional	  telephone	  attempts.	  (Figure	  1.)	  	  	   Figure	  1.	  Study	  Overview	  	  
	  	  Distribution	  of	  roles	  in	  conducting	  this	  thesis	  work	  The	  original	  study	  was	  designed	  by	  Drs.	  Basmah	  Safdar	  and	  Morgan	  Soffler,	  to	  understand	  the	  relationship	  between	  perceived	  stress	  and	  recurrent	  chest	  pain.	  For	  the	  purposes	  of	  my	  thesis	  research,	  I	  utilized	  the	  same	  data	  set	  to	  explore	  a	  secondary	  analysis	  to	  answer	  my	  related	  hypothesis	  that	  symptoms	  of	  depression	  correlate	  independently	  with	  recurrent	  chest	  pain.	  Dr	  Basmah	  Safdar	  served	  as	  my	  









                Excluded (n=408; 48.0%)
-Patient refusal (38.6%)
-Non-English speaker (28.5%)
-Condition precludes interview (5.9%)
-Recent drug use (3.4%)
-Inadequate contact information (0.5%)
-Admitted to CPC in past year (3.0%)
-Other (21.7%)
Missing data on PHQ-8 (n=7; 2.1%)
Lost to follow-up (n=108; 24.4%)
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research	  advisor	  throughout	  the	  study.	  I	  was	  primarily	  responsible	  for	  enrollment	  during	  the	  first	  year	  of	  the	  study,	  and	  other	  team	  members	  contributed	  as	  their	  schedules	  allowed.	  After	  this	  time,	  I	  trained	  research	  associate	  Matt	  Naftilan,	  MS,	  to	  conduct	  enrollment,	  and	  he	  took	  over	  enrollment	  moving	  forward.	  I	  also	  trained	  two	  undergraduate	  students,	  who	  participated	  briefly	  as	  members	  of	  our	  team.	  Additionally,	  Matt	  created	  and	  managed	  our	  electronic	  research	  database.	  All	  researchers,	  including	  myself,	  shared	  the	  duty	  of	  making	  follow-­‐up	  calls.	  Follow-­‐up	  letters	  were	  mailed	  by	  Senior	  Administrative	  Assistant,	  Jaydale	  Codrington-­‐Poyotte,	  who	  also	  organized	  team	  meetings.	  I	  wanted	  to	  be	  directly	  involved	  in	  the	  statistical	  analysis,	  and	  was	  trained	  in	  SPSS	  by	  a	  research	  colleague,	  Thomas	  Adams,	  PhD,	  who	  is	  affiliated	  with	  Yale’s	  Psychiatry	  department.	  Tom	  has	  extensive	  experience	  with	  SPSS	  and	  has	  taught	  statistics	  at	  the	  graduate	  level.	  James	  Dizuria,	  a	  faculty	  biostatistician	  in	  the	  department	  of	  emergency	  medicine	  and	  a	  co-­‐investigator	  on	  this	  study,	  also	  provided	  consultation	  and	  interpretation	  of	  statistics	  and	  methods.	  Additional	  team	  members	  and	  collaborators	  not	  mentioned	  here	  are	  referenced	  in	  the	  acknowledgements	  and	  authors	  sections	  of	  this	  report.	  	  Study	  Participants	  We	  enrolled	  patients	  in	  the	  Chest	  Pain	  Center	  (CPC)	  unit	  of	  the	  Yale-­‐New	  Haven	  Hospital	  Emergency	  Department,	  usually	  between	  the	  hours	  of	  9	  a.m.	  to	  2	  p.m.,	  while	  patients	  awaited	  their	  stress	  tests.	  Patients	  admitted	  to	  the	  CPC,	  have	  typically	  presented	  to	  the	  Emergency	  Department	  with	  symptoms	  concerning	  for	  an	  acute	  coronary	  syndrome,	  and	  been	  immediately	  assessed	  by	  medical	  staff.	  With	  an	  initial	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work-­‐up	  negative	  for	  an	  acute	  coronary	  syndrome,	  they	  may	  be	  considered	  for	  further	  observation	  and	  testing	  in	  the	  CPC.	  Our	  study	  inclusion	  criteria	  were	  in	  accord	  with	  criteria	  for	  CPC	  admission,	  based	  on	  American	  Heart	  Association	  low-­‐intermediate	  risk	  profile,	  negative	  initial	  serum	  troponin,	  and	  a	  normal	  or	  non-­‐ischemic	  ECG.24	  Also,	  as	  a	  voluntary	  study,	  patient	  consent	  to	  participate	  was	  required.	  Specific	  exclusion	  criteria	  were	  as	  follows:	  
• Patient	  seen	  in	  CPC	  within	  the	  past	  year	  
• Non-­‐English	  speaking	  
• Suffering	  from	  a	  condition	  that	  precludes	  interview	  (i.e.	  cognitive	  or	  communication	  impairment)	  
• Acute	  Coronary	  Syndrome	  (positive	  EKG	  and/or	  cardiac	  enzymes)	  
• Known	  pregnancy	  
• Unable	  to	  provide	  contact	  number	  for	  follow-­‐up	  study	  
• Active	  psychiatric	  condition	  (psychosis	  or	  suicidal	  ideation)	  
• Used	  heroin,	  cocaine	  or	  alcohol	  in	  the	  past	  72	  hours	  
• In	  police	  custody	  at	  the	  time	  of	  presentation	  	  Measures	  The	  following	  questionnaires	  were	  filled	  out	  by	  patients,	  and	  on	  some	  occasion	  were	  administered	  by	  research	  staff.	  	  	  
The	  eight-­‐item	  Patient	  Health	  Questionnaire	  (PHQ-­‐8)	  was	  used	  to	  assess	  depressive	  symptoms.	  It	  is	  a	  self-­‐administered	  instrument	  that	  is	  based	  on	  DSM	  criteria	  for	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major	  depressive	  disorder,	  and	  is	  a	  validated	  tool	  for	  detection	  of	  depressive	  disorder	  and	  depression	  severity.25-­‐27	  Items	  present	  statements,	  such	  as	  “little	  interest	  or	  pleasure	  in	  doing	  things”	  and	  “feeling	  tired	  or	  having	  little	  energy,”	  and	  the	  patient	  assigns	  a	  frequency	  using	  a	  Likert-­‐type	  scale,	  ranging	  from	  zero	  (not	  at	  all)	  to	  3	  (nearly	  everyday),	  with	  final	  scores	  ranging	  from	  0	  to	  24.	  	  	  The	  PHQ	  is	  a	  screening	  tool	  for	  both	  diagnosis	  and	  assessment	  of	  symptom	  severity.	  We	  used	  a	  cutoff	  score	  ≥10,	  which	  is	  highly	  sensitive	  and	  specific	  for	  diagnosis	  of	  major	  depressive	  disorder.	  A	  large	  population-­‐based	  study	  showed	  a	  PHQ-­‐8	  cutoff	  score	  ≥10	  to	  have	  a	  sensitivity	  and	  specificity	  for	  major	  depressive	  disorder	  of	  100%	  and	  95%,	  respectively.	  For	  any	  depressive	  disorder,	  the	  sensitivity	  and	  specificity	  were	  70%	  and	  98%,	  respectively.28	  We	  defined	  depression	  severity	  by	  previously	  described	  PHQ-­‐8	  score	  intervals:	  0-­‐4(none),	  5-­‐9(mild),	  10-­‐14(moderate),	  15-­‐19(moderately	  severe),	  20-­‐24(severe).27,28	  	  Somatic	  and	  cognitive	  dimensions	  of	  PHQ	  depressive	  symptoms	  have	  been	  validated	  previously	  with	  high	  Cronbach	  α	  statistics	  of	  0.77	  and	  0.84,	  respectively.17,21,29	  
Somatic	  symptoms	  include	  sleep,	  energy	  level,	  appetite	  and	  psychomotor	  agitation,	  and	  cognitive	  symptoms	  include	  interest,	  depressed	  mood,	  concentration,	  negative	  feelings	  toward	  self	  and	  suicidal	  ideation.	  Of	  note,	  the	  PHQ-­‐8	  differs	  from	  the	  PHQ-­‐9	  in	  that	  it	  lacks	  an	  item	  to	  assess	  suicidal	  ideation.	  However,	  the	  value	  of	  this	  item	  in	  the	  general	  population	  has	  been	  questioned,	  and	  a	  large	  study	  of	  patients	  with	  CAD	  concluded	  the	  item	  of	  suicidal	  ideation	  to	  be	  of	  questionable	  accuracy,	  and	  of	  no	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benefit	  when	  assessing	  depression	  in	  this	  patient	  population.30	  Moreover,	  the	  PHQ-­‐8	  and	  PHQ-­‐9	  correlate	  strongly,	  and	  have	  comparable	  operating	  characteristics	  and	  validity.27,31	  We	  preferred	  the	  PHQ-­‐8	  also	  because	  patients	  with	  active	  suicidal	  ideation	  were	  automatically	  excluded	  from	  CPC	  admission	  prior	  to	  being	  considered	  for	  study	  enrollment.	  	  
The	  Clinical	  Anxiety	  Scale	  (CAS)	  was	  used	  to	  assess	  anxiety.	  The	  CAS	  is	  a	  25-­‐item	  self-­‐administered	  tool,	  designed	  to	  distinguish	  between	  anxious	  and	  non-­‐anxious	  states.	  
32	  Each	  item	  presents	  a	  statement,	  such	  as	  “I	  feel	  calm”	  or	  “I	  am	  free	  from	  senseless	  or	  unpleasant	  thoughts,”	  and	  the	  patient	  selects	  the	  frequency	  at	  which	  they	  identify	  with	  the	  statement	  on	  a	  scale	  ranging	  from	  1(rarely	  or	  none	  of	  the	  time)	  to	  5(most	  or	  all	  of	  the	  time).	  Final	  scores	  range	  from	  twenty-­‐five	  to	  one	  hundred	  twenty-­‐five,	  and	  a	  score	  of	  thirty	  is	  considered	  to	  be	  the	  clinical	  cutting	  score	  that	  discriminates	  between	  clinically	  anxious	  and	  non-­‐anxious	  patients.	  The	  CAS	  has	  high	  reliability	  and	  high	  validity,	  compared	  to	  numerous	  alternative	  anxiety	  scales.	  32	  	  
The	  ten-­‐item	  Perceived	  Stress	  Scale	  (PSS-­‐10)	  was	  used	  to	  assess	  psychological	  stress.	  Based	  on	  its	  properties	  and	  past	  performance,	  the	  PSS	  is	  suggested	  for	  use	  in	  studies	  investigating	  factors	  that	  influence	  or	  are	  influenced	  by	  stress	  appraisal.33,34	  It	  was	  designed	  to	  assess	  global	  stress	  appraisal	  in	  all	  aspects	  of	  life	  over	  the	  past	  month,	  and	  is	  not	  limited	  to	  appraisal	  of	  particular	  situations.34	  The	  PSS-­‐10	  has	  demonstrated	  internal	  reliability	  and	  validity33-­‐35.	  The	  PSS-­‐10	  has	  ten	  items	  formatted	  as	  questions,	  such	  as	  “In	  the	  last	  month,	  how	  often	  have	  you	  felt	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difficulties	  were	  piling	  up	  so	  high	  that	  you	  could	  not	  overcome	  them?”	  The	  patient	  selects	  an	  answer	  on	  a	  5-­‐point	  scale	  ranging	  from	  0(never)	  to	  4(very	  often),	  with	  final	  scores	  ranging	  from	  zero	  to	  forty.	  	  	  Follow-­‐up	  Survey	  To	  survey	  prospective	  outcomes,	  we	  called	  each	  patient	  one-­‐month	  following	  the	  date	  of	  enrollment.	  To	  assess	  any	  recurrence	  of	  chest	  pain,	  we	  asked	  the	  following	  question:	  “in	  the	  past	  four	  weeks	  did	  you	  have	  any	  discomfort	  in	  your	  chest.”	  The	  patient	  was	  then	  asked	  to	  rate	  the	  persistence	  of	  their	  symptoms	  on	  a	  five-­‐point	  scale:	  0(none),	  1(1-­‐2	  times),	  2(>3	  times	  per	  week),	  3(1-­‐3	  times	  per	  day),	  and	  4(>4	  times	  per	  day).	  We	  also	  asked	  about	  follow-­‐up	  doctors	  visits	  and	  repeat	  visits	  to	  the	  emergency	  room.	  	  	  Data	  Collection	  and	  Processing	  Patients	  provided	  information	  on	  demographics,	  past	  medical	  history,	  medication	  use,	  and	  contact	  information	  on	  initial	  interview.	  A	  small	  gift	  of	  chocolate	  was	  provided	  as	  a	  token	  of	  gratitude,	  and	  sugar-­‐free	  chocolate	  was	  available	  to	  patients	  with	  a	  history	  of	  diabetes.	  All	  data	  entries	  were	  made	  directly	  in	  FileMaker	  Pro	  installed	  on	  a	  password	  protected,	  encrypted,	  backed	  up	  research	  iPad.	  When	  not	  in	  use,	  this	  iPad	  was	  kept	  locked	  in	  a	  research	  locker	  in	  the	  emergency	  department.	  We	  scored	  surveys	  on	  completion	  and	  entered	  raw	  scores	  into	  the	  database.	  Hard	  copies	  were	  retained	  in	  a	  secured	  hospital	  location	  for	  future	  cross-­‐reference.	  The	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same	  database	  was	  used	  for	  follow-­‐up	  completion.	  We	  conducted	  chart	  reviews	  through	  Epic	  to	  fill	  in	  any	  missing	  information,	  where	  appropriate.	  	  	  Statistical	  Analysis	  Recurrent	  chest	  pain	  was	  defined	  as	  any	  occurrence	  of	  chest	  discomfort	  after	  discharge	  noted	  on	  one-­‐month	  follow-­‐up	  telephone	  call.	  Current	  depression	  for	  this	  manuscript	  was	  defined	  by	  PHQ-­‐8	  score	  ≥10.	  Burden	  of	  depression	  was	  considered	  as	  the	  number	  of	  patients	  with	  PHQ-­‐8	  score	  ≥10	  and/or	  receiving	  ongoing	  treatment	  with	  anti-­‐depressant	  medications.	  Unrecognized	  depression	  was	  the	  burden	  of	  depression	  minus	  the	  patients	  who	  were	  receiving	  anti-­‐depressant	  medication.	  	  For	  descriptive	  purposes,	  categorical	  data	  were	  characterized	  as	  frequency/total	  sample	  size	  (%)	  and	  continuous	  data	  were	  characterized	  as	  mean	  (Standard	  Deviation).	  Age	  was	  considered	  skewed	  data	  and	  characterized	  by	  median	  (IQR).	  Independent	  sample	  t	  tests	  were	  used	  to	  compare	  means	  for	  sample	  sizes	  greater	  than	  thirty,	  and	  equal	  variance	  of	  standard	  deviations	  was	  applied	  if	  significance	  of	  Levene’s	  test	  was	  less	  than	  .05.	  Univariate	  group	  wise	  comparisons	  of	  categorical	  data	  were	  carried	  out	  using	  the	  Pearson	  chi	  square	  test	  (χ2),	  and	  univariate	  interactions	  between	  ordinal	  and	  continuous	  data	  were	  tested	  using	  Spearman’s	  rank	  correlation	  coefficient	  (rs).	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Multivariate	  binary	  logistic	  regression	  analysis	  was	  used	  to	  test	  for	  independent	  correlations	  between	  depression	  as	  measured	  by	  PHQ-­‐8	  scores	  and	  recurrence	  of	  chest	  pain.	  For	  our	  analysis,	  we	  treated	  PHQ-­‐8	  scores	  as	  continuous	  numerical	  variables.	  Additional	  covariates	  chosen	  for	  modeling	  were	  selected	  a-­‐priori	  based	  on	  our	  clinical	  impression	  of	  their	  possible	  confounding	  effect	  on	  the	  relationship	  between	  depression	  and	  chest	  pain.	  Cardiac	  risk	  factors	  (hypertension,	  dyslipidemia,	  diabetes,	  smoking,	  history	  of	  coronary	  heart	  disease,	  pertinent	  family	  history	  of	  coronary	  heart	  disease)	  were	  considered	  binary	  and	  determined	  through	  patient	  report.	  Race	  was	  considered	  Caucasian/non-­‐Caucasian,	  marital	  status	  was	  considered	  married/non-­‐married,	  employment	  was	  yes/no,	  and	  high	  school	  degree	  was	  yes/no.	  When	  patients	  were	  unable	  to	  answer	  questions,	  or	  interview	  time	  did	  not	  allow	  completion	  of	  survey	  topics,	  chart	  review	  was	  used	  to	  complete	  the	  data.	  Five	  stepwise	  models	  were	  constructed	  to	  observe	  the	  effects	  of	  different	  categories	  of	  covariates.	  	  	  Where	  applicable,	  all	  tests	  used	  95%	  confidence	  intervals	  (95%	  CI),	  and	  the	  level	  of	  significance	  was	  at	  the	  level	  of	  p	  value	  <	  .05.	  All	  analyses	  were	  performed	  using	  the	  Statistical	  Package	  for	  the	  Social	  Sciences	  (SPSS	  for	  Macintosh,	  Version	  22.0).	  
	  
Results	  	  
	  On	  days	  when	  enrollment	  was	  carried	  out,	  all	  patients	  who	  met	  eligibility	  criteria	  were	  approached.	  Between	  July	  30th	  2013	  to	  January	  31st	  2015	  a	  total	  of	  850	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patients	  were	  invited	  to	  participate	  in	  our	  study	  and	  442	  (52.0%)	  agreed	  to	  do	  so.	  The	  majority	  of	  exclusions	  were	  made	  on	  the	  basis	  of	  language	  and	  patient	  refusal	  to	  participate,	  and	  further	  details	  of	  excluded	  patients	  can	  be	  seen	  in	  Figure	  1.	  Of	  the	  enrolled	  patients,	  334	  completed	  follow-­‐up,	  for	  a	  rate	  of	  75.6%.	  Of	  these	  patients,	  seven	  were	  excluded	  for	  missing	  or	  aberrant	  PHQ-­‐8	  survey	  data,	  leaving	  a	  final	  sample	  of	  327	  patients	  for	  analysis.	  The	  median	  age	  of	  the	  analytic	  sample	  was	  fifty-­‐three	  years,	  and	  the	  majority	  were	  women	  (n=184;	  56.3%),	  Caucasian	  (n=222;	  67.9%),	  married/cohabiting	  (n=209;	  63.9%),	  employed	  (n=224;	  68.5%),	  and	  had	  a	  high	  school	  degree	  or	  more	  (94.8%).	  (Table	  1.)	  Majority	  of	  the	  patients	  had	  at	  least	  one	  cardiac	  risk	  factor;	  46.8%	  had	  hypertension,	  40.4%	  had	  dyslipidemia	  and	  17%	  had	  diabetes.	  Personal	  and	  family	  history	  of	  coronary	  heart	  disease,	  as	  well	  as	  high-­‐risk	  behaviors	  -­‐cigarette	  smoking	  and	  alcohol	  consumption-­‐	  were	  also	  reported	  in	  Table	  1.	  	  Baseline	  psychological	  assessments	  can	  be	  seen	  in	  Table	  1.	  	  More	  than	  two-­‐thirds	  of	  enrolled	  patients	  had	  chest	  pain	  on	  at	  least	  one	  occasion	  following	  discharge	  from	  the	  hospital	  (n=115;	  35.2%).	  Compared	  to	  patients	  without	  recurrent	  symptoms,	  these	  patients	  tended	  to	  be	  slightly	  younger	  (51	  versus	  55	  years	  of	  age),	  more	  female	  (64.3%),	  less	  Caucasian	  (63.5%	  versus	  70.3%)	  and	  less	  partnered	  (55.7%	  versus	  68.4%).	  Hypertension	  and	  dyslipidemia	  were	  less	  present	  in	  the	  patients	  with	  recurrent/persistent	  chest	  pain	  (38.3%	  and	  34.8%	  versus	  51.4%	  and	  43.4%),	  but	  other	  cardiac	  risk	  factors	  were	  comparable	  between	  the	  two	  groups.	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Table	  1:	  Baseline	  Demographics	  of	  Patients	  Enrolled	  in	  the	  Study.	  	  	   	  
Overall	  
	  








n	  =	  115	  	  
p	  
Value*	  
Socio-­‐Demographics	   	   	   	   	  	  	  	  Age,	  median	  (IQR),	  yrs	  	   53	  (15.0)	   55	  (17.5)	   51	  (12.3)	   	  	  	  	  Gender	   	   	   	   .023	  	  	  	  	  	  	  	  	  Female,	  n	  (%)	   184	  (56.3)	   110	  (51.9)	   74	  (64.3)	   	  	  	  	  	  	  	  	  	  Male,	  n	  (%)	   143	  (43.7)	   102	  (48.1)	   41	  (35.7)	   	  	  	  	  Race	   	   	   	   	  	  	  	  	  	  	  	  	  White,	  n	  (%)	   222	  (67.9)	   149	  (70.3)	   73	  (63.5)	   .154	  	  	  	  	  	  	  	  	  Black,	  n	  (%)	   68	  (20.8)	   40	  (18.9)	   28	  (24.3)	   .269	  	  	  	  	  	  	  	  	  Hispanic,	  n	  (%)	   23	  (7.0)	   12	  (5.7)	   11	  (9.6)	   .199	  	  	  	  	  	  	  	  	  Other,	  n	  (%)	   14	  	  (4.3)	   11	  (5.2)	   3	  (2.6)	   	  	  	  	  Relationship	  Status	   	   	   	   	  	  	  	  	  	  	  	  	  Married/cohabiting,	  n	  (%)	   209	  (63.9)	   145	  (68.4)	   64	  (55.7)	   .015	  	  	  	  	  	  	  	  	  Single,	  n	  (%)	   66	  (20.2)	   37	  (17.5)	   29	  (25.2)	   .058	  	  	  	  	  	  	  	  	  Divorced,	  n	  (%)	   40	  (12.2)	   18	  (8.5)	   22	  (19.1)	   .006	  	  	  	  	  	  	  	  	  Widowed,	  n	  (%)	   12	  (3.7)	   12	  (5.7)	   0	  (0.0)	   .009	  	  	  	  Highest	  Degree	  of	  Education	   	   	   	   	  	  	  	  	  	  	  	  	  Did	  not	  complete	  H.S.,	  n	  (%)	   17	  (5.2)	   9	  (4.2)	   8	  (7.0)	   .305	  	  	  	  	  	  	  	  	  H.S.	  diploma	  or	  GED,	  n	  (%)	   164	  (50.2)	   109	  (51.4)	   55	  (47.8)	   .615	  	  	  	  	  	  	  	  	  College	  degree,	  n	  (%)	   146	  (44.6)	   94	  (44.3)	   52	  (45.2)	   .961	  	  	  	  Employment	  Status	   	   	   	   	  	  	  	  	  	  	  	  	  Employed,	  n	  (%)	   224	  (68.5)	   142	  (67.0)	   82	  (71.3))	   .379	  	  	  	  	  	  	  	  	  Retired,	  n	  (%)	   54	  (16.5)	   42	  (19.8)	   12	  (10.4)	   .026	  	  	  	  	  	  	  	  	  Student/homemaker,	  n	  (%)	   10	  (3.1)	   6	  (2.8)	   4	  (3.5)	   .761	  	  	  	  	  	  	  	  	  Unemployed,	  n	  (%)	   39	  (11.9)	   22	  (10.4)	   17	  (14.8)	   .379	  	  	  	  Insurance	  Coverage	   	   	   	   	  	  	  	  	  	  	  	  	  Uninsured,	  n	  (%)	   15	  (4.6)	   11	  (5.2)	   4	  (3.5)	   .465	  
Cardiac	  Risk	  Factors	   	   	   	   	  	  	  	  	  	  	  	  	  CHD,	  n	  %	   21	  (6.4)	   12	  (5.7)	   9	  (7.8)	   .465	  	  	  	  	  	  	  	  	  HTN,	  n	  (%)	   153	  (46.8)	   109	  (51.4)	   44	  (38.3)	   .032	  	  	  	  	  	  	  	  	  Dyslipidemia,	  n	  (%)	   132	  (40.4)	   92	  (43.4)	   40	  (34.8)	   .108	  	  	  	  	  	  	  	  	  Diabetes,	  n	  (%)	   56	  (17.1)	   35	  (16.5)	   21	  (18.3)	   .513	  	  	  	  	  	  	  	  	  Smoker,	  n	  (%)	   52	  (15.9)	   32	  (15.1)	   20	  (17.4)	   .623	  	  	  	  	  	  	  	  	  Family	  history,	  n	  %	   88	  (26.9)	   58	  (27.4)	   30	  (26.1)	   .751	  Regular	  Alcohol,	  n	  (%)	   25	  (7.6)	   19	  (9.0)	   6	  (5.2)	   .212	  
Psychological	  Assessments	   	   	   	   	  	  	  	  	  	  	  	  	  Anti-­‐depression	  Rx,	  n	  (%)	   54	  (16.5)	   29	  (13.7)	   25	  (21.7)	   .033	  	  	  	  	  	  	  	  	  Anti-­‐anxiety	  Rx,	  n	  (%)	   58	  (17.7)	   32	  (15.1)	   26	  (22.6)	   .052	  	  	  	  	  	  	  	  	  CAS	  score,	  mean	  (SD)	   43.19	  (14.03)	   41.51	  (12.52)	   46.29	  (16.07)	   .004	  	  	  	  	  	  	  	  	  PSS-­‐10	  score,	  mean	  (SD)	   16.69	  (8.41)	   16.21	  (7.88)	   17.57	  (9.29)	   .141	  CP,	  chest	  pain;	  IQR,	  interquartile	  range;	  HS,	  high	  school;	  GED,	  general	  educational	  development;	  CHD,	  coronary	  heart	  disease;	  HTN,	  hypertension;	  Rx,	  medication;	  CAS,	  clinical	  anxiety	  scale;	  PSS,	  perceived	  stress	  scale.	  	  *Statistical	  significance	  at	  p<	  .05	  for	  Pearson	  Chi	  square	  test	  or	  independent	  T	  test,	  as	  appropriate.	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Primary	  Aim	  1:	  Depressive	  symptom	  burden	  in	  CPC	  patients	  A	  heavy	  burden	  of	  depression	  was	  present	  in	  patients	  admitted	  to	  the	  cardiac	  observation	  unit.	  (Table	  2.)	  An	  overall	  29%	  had	  some	  evidence	  of	  depression,	  be	  it	  high	  symptom	  scores	  or	  current	  treatment	  for	  depression.	  The	  mean	  PHQ-­‐8	  score	  was	  M=5.58	  (SD=5.43),	  but	  nearly	  one	  fifth	  had	  PHQ-­‐8	  scores	  ≥10	  (n=64;	  19.6%).	  Sixteen	  and	  a	  half	  percent	  had	  pre-­‐existing	  diagnosis	  of	  depression	  and	  were	  on	  treatment.	  Comparing	  PHQ-­‐8	  scores	  to	  treated	  depression,	  we	  identified	  forty-­‐one	  (12.5%)	  patients	  with	  new	  or	  unrecognized	  depressive	  symptoms.	  Men	  and	  women	  had	  similar	  PHQ-­‐8	  mean	  scores	  (M=5.62,	  SD=5.12	  and	  M=5.54,	  SD=5.05,	  respectively)	  and	  similar	  proportions	  of	  PHQ-­‐8	  scores	  ≥10	  (18.2%	  and	  20.7%,	  respectively).	  However,	  there	  were	  more	  women	  receiving	  treatment	  for	  depression	  (22.3%	  versus	  9.1%),	  leading	  to	  higher	  estimates	  of	  overall	  depressive	  burden	  for	  women	  (33.2%	  versus	  23.8%).	  	  Primary	  Aim	  2:	  Depressive	  symptom	  burden	  and	  recurrent/persistent	  chest	  pain	  The	  symptom	  burden	  of	  depression	  was	  significantly	  higher	  in	  patients	  with	  recurrent/persistent	  chest	  pain,	  compared	  to	  those	  without.	  (Table	  2.)	  This	  was	  reflected	  in	  mean	  PHQ-­‐8	  scores,	  in	  PHQ-­‐8	  scores	  ≥10,	  and	  in	  the	  proportion	  of	  patients	  receiving	  treatment	  for	  depression.	  Patient	  with	  recurrent/persistent	  chest	  pain	  were	  significantly	  more	  likely	  to	  have	  higher	  average	  PHQ-­‐8	  scores	  (M=6.94,	  SD=5.58)	  than	  patients	  without	  recurrent	  chest	  pain	  (M=4.84,	  SD=4.63)	  (p=	  .001).	  Interestingly,	  cognitive	  and	  somatic	  symptom	  dimensions	  both	  contributed	  to	  this	  relationship.	  The	  proportion	  of	  patients	  with	  PHQ-­‐8	  scores	  ≥10	  was	  27.8%	  when	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presenting	  with	  recurrent/persistent	  chest	  pain,	  compared	  to	  15.1%	  in	  patients	  without	  recurrence	  of	  chest	  pain.	  In	  addition,	  more	  than	  one	  fifth	  (21.7%)	  of	  patients	  with	  recurrent/persistent	  chest	  pain	  reported	  ongoing	  treatment	  of	  depression	  with	  anti-­‐depressant	  medications,	  compared	  to	  13.7%	  of	  asymptomatic	  patients.	  For	  clinical	  context,	  the	  overall	  burden	  of	  depression	  was	  37.4%	  of	  patients	  with	  recurrent/persistent	  chest	  pain,	  compared	  to	  24.5%	  of	  patients	  without	  symptoms	  (χ2(1,	  N=327)=5.61,	  p=	  .018).	  	  	  PHQ-­‐8	  scores	  can	  be	  used	  to	  further	  describe	  the	  distribution	  of	  depressive	  symptoms.	  The	  majority	  of	  patients	  (57.5%)	  without	  recurrent/persistent	  chest	  pain	  had	  very	  low	  PHQ-­‐8	  scores	  indicating	  ‘no	  depression,’	  while	  less	  than	  half	  (43.5%)	  of	  patients	  with	  recurrent/persistent	  chest	  pain	  had	  scores	  in	  this	  low	  range.	  The	  two	  groups	  were	  nearly	  matched	  with	  about	  27-­‐29%	  percent	  of	  patients	  having	  ‘mild	  depression,’	  and	  higher	  scores	  were	  more	  prevalent	  in	  patients	  with	  recurrent/persistent	  chest	  pain.	  	  	  Patients	  with	  more	  severe	  depression	  experienced	  chest	  pain	  more	  frequently	  than	  those	  with	  milder	  depressive	  symptoms,	  and	  Spearman	  testing	  of	  this	  relationship	  revealed	  a	  significant	  low	  positive	  correlation	  (rs=0.222,	  n=327,	  p=	  .000).	  Similar	  results	  were	  seen	  for	  depressive	  symptom	  dimensions.	  Cognitive	  symptoms	  showed	  a	  very	  low	  positive	  correlation	  (rs=0.196,	  n=321,	  p=	  .000),	  and	  somatic	  scores	  also	  fell	  to	  a	  very	  low	  positive	  correlation	  (rs=0.179,	  n=321,	  p<	  .001),	  both	  statistically	  significant.	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p	  Value*	  	  
All	  patients	   n	  =	  327	   n	  =	  212	   n	  =	  115	   	  Treated depression,	  n	  (%)	   54	  (16.5)	   29	  (13.7)	   25	  (21.7)	   .061	  PHQ-­‐8	  score	  ≥10,	  n	  (%)	   64	  (19.6)	   32	  (15.1)	   32	  (27.8)	   .006	  Burden	  of depression,	  n	  (%)	   95	  (29.1)	   52	  (24.5)	   43	  (37.4)	   .018	  Unrecognized	  depression,	  n	  (%)	   41	  (12.5)	   24	  (11.3)	   17	  (14.8)	   .391	  PHQ-­‐8	  levels	  of	  depression,	  n	  (%)	   	   	   	   .003	  	  	  	  	  	  	  	  	  no	  depression	   172	  (52.6)	   122	  (57.5)	   50	  (43.5)	   	  	  	  	  	  	  	  	  	  mild	  depression	   91	  (27.8)	   58	  (27.4)	   33	  (28.7)	   	  	  	  	  	  	  	  	  	  moderate	  depression	   40	  (12.2)	   23	  (10.8)	   17	  (14.8)	   	  	  	  	  	  	  	  	  	  moderately	  severe	  depression	   17	  (5.2)	   6	  (2.8)	   11	  (9.6)	   	  	  	  	  	  	  	  	  	  severe	  	  depression	   7	  (2.1)	   3	  (1.4)	   4	  (3.5)	   	  PHQ-­‐8	  total	  score,	  mean	  (SD)	   5.58	  (5.08)	   4.84	  (4.63)	   6.94	  (5.58)	   .001	  PHQ-­‐8	  cognitive	  score,	  mean	  (SD)	   2.19	  (2.89)	   1.84	  (2.60)	   2.84	  (3.28)	   .006	  PHQ-­‐8	  somatic	  score,	  mean	  (SD)	   3.40	  (2.73)	   3.07	  (2.60)	   4.00	  (2.86)	   .003	  
Women	   n	  =	  184	   n	  =	  110	   n	  =	  74	   	  Treated depression,	  n	  (%)	   41	  (22.3)	   22	  (20.0)	   19	  (25.7)	   .364	  PHQ-­‐8	  score	  ≥10,	  n	  (%)	   38	  (20.7)	   14	  (12.7)	   24	  (32.4)	   .001	  Burden	  of depression,	  n	  (%)	   61	  (33.2)	   29	  (26.4)	   32	  (43.2)	   .023	  Unrecognized	  depression,	  n	  (%)	   20	  (10.9)	   8	  (7.3)	   12	  (16.2)	   .064	  PHQ-­‐8	  levels	  of	  depression,	  n	  (%)	   	   	   	   .000	  	  	  	  	  	  	  	  	  no	  depression	   98	  (53.3)	   70	  (63.6)	   28	  (37.8)	   	  	  	  	  	  	  	  	  	  mild	  depression	   48	  (26.1)	   26	  (23.6)	   22	  (29.7)	   	  	  	  	  	  	  	  	  	  moderate	  depression	   25	  (13.6)	   10	  (9.1)	   15	  (20.3)	   	  	  	  	  	  	  	  	  	  moderately	  severe	  depression	   9	  (4.9)	   3	  (2.7)	   6	  (8.1)	   	  	  	  	  	  	  	  	  	  severe	  depression	   4	  (2.2)	   1	  (0.9)	   3	  (4.1)	   	  PHQ-­‐8	  total	  score,	  mean	  (SD)	   5.54	  (5.05)	   4.44	  (4.60)	   7.19	  (5.27)	   .000	  PHQ-­‐8	  cognitive	  score,	  mean	  (SD)	   2.11	  (2.85)	   1.62	  (2.56)	   2.82	  (3.11)	   .007	  PHQ-­‐8	  somatic	  score,	  mean	  (SD)	   3.47	  (2.78)	   2.93	  (2.68)	   4.25	  (2.75)	   .002	  
Men	   n	  =	  143	   n	  =	  102	   n	  =	  41	   	  Treated depression,	  n	  (%)	   13	  (9.1)	   7	  (6.9)	   6	  (14.6)	   .144	  PHQ-­‐8	  score	  ≥10,	  n	  (%)	   26	  (18.2)	   18	  (17.6)	   8	  (19.5)	   .798	  Burden	  of depression,	  n	  (%)	  	   34	  (23.8)	   23	  (22.5)	   11	  (26.8)	   .587	  Unrecognized	  depression,	  n	  (%)	   21	  (14.7)	   16	  (15.7)	   5	  (12.2)	   .594	  PHQ-­‐8	  levels	  of	  depression,	  n	  (%)	   	   	   	   .986	  	  	  	  	  	  	  	  	  no	  depression	   74	  (51.7)	   52	  (50.1)	   22	  (53.7)	   	  	  	  	  	  	  	  	  	  mild	  depression	   43	  (30.1)	   32	  (31.4)	   11	  (26.8)	   	  	  	  	  	  	  	  	  	  moderate	  depression	   15	  (10.5)	   13	  (12.7)	   2	  (4.9)	   	  	  	  	  	  	  	  	  	  moderately	  severe	  depression	   8	  (5.6)	   3	  (2.9)	   5	  (12.2)	   	  	  	  	  	  	  	  	  	  severe	  depression	   3	  (2.1)	   2	  (2.0)	   1	  (2.4)	   	  PHQ-­‐8	  total	  score,	  mean	  (SD)	   5.62	  (5.12)	   5.28	  (4.64)	   6.49	  (6.13)	   .258	  PHQ-­‐8	  cognitive	  score,	  mean	  (SD)	   2.30	  (2.94)	   2.07	  (2.63)	   2.88	  (3.60)	   .203	  PHQ-­‐8	  somatic	  score,	  mean	  (SD)	  	   3.30	  (2.67)	   3.21	  (2.52)	   3.55	  (3.03)	   .491	  	  CP,	  chest	  pain;	  Treated	  depression,	  patients	  taking	  anti-­‐depressant	  medications;	  PHQ,	  patient	  health	  questionnaire;	  Burden	  of	  depression,	  number	  of	  treated	  depression	  and/or	  PHQ-­‐8	  score	  ≥10;	  Unrecognized	  depression,	  Burden	  of	  depression	  minus	  patients	  with	  Treated	  depression.	  *Statistical	  significance	  at	  p<	  .05	  for	  Pearson	  Chi	  square	  test,	  independent	  T	  test,	  or	  Spearman	  rank	  correlation,	  as	  appropriate.	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Independent	  relationship	  of	  depressive	  symptoms	  and	  recurrent/persistent	  chest	  pain	  Multivariate	  logistic	  regression	  analysis	  established	  an	  independent	  relationship	  between	  depressive	  symptom	  severity	  and	  recurrence	  of	  chest	  pain.	  (Table	  3.)	  The	  Hosmer-­‐Lemeshow	  goodness-­‐of-­‐fit	  test	  indicated	  that	  the	  logistic	  model	  suitably	  fit	  the	  data	  (Chi-­‐square	  9.064,	  df	  8,	  p=	  .337).	  Stepwise	  addition	  of	  covariates,	  including	  demographics,	  cardiac	  risk	  factors	  and	  psychological	  test	  scores	  altered	  the	  OR	  for	  recurrent	  chest	  pain,	  but	  the	  relationship	  remained	  significant.	  The	  PHQ-­‐8	  is	  a	  continuous	  variable	  with	  a	  maximum	  score	  of	  24,	  and	  the	  OR	  observed	  for	  the	  most	  complete	  model	  indicates	  that	  for	  each	  single	  point	  increase	  in	  PHQ-­‐8	  score,	  there	  is	  an	  7.5%	  increase	  in	  the	  odds	  of	  having	  recurrent	  chest	  pain	  (model	  5:	  OR=1.075;	  95%	  CI=1.005,	  1.149;	  p=	  .035).	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Covariates	  Included	  in	  the	  Model	  
	   	   	   	  1	   1.084	  	  (1.036,	  1.134)	   .000	   PHQ-­‐8	  	  
	  	  2	   	  1.074	  (1.025,	  1.125)	   	  .003	   	  PHQ-­‐8,	  age,	  gender,	  race	  	  	  	  3	   	  1.069	  (1.020,	  1.122)	   	  .006	   	  PHQ-­‐8,	  age,	  gender,	  race,	  marital	  status,	  education	  level,	  employment	  status	  	  	  4	   	  	  1.078	  (1.026,	  1.132)	  
	  .003	   	  PHQ-­‐8,	  age,	  gender,	  race,	  marital	  status,	  education	  level,	  employment	  status,	  cardiac	  
risk	  factors	  (HTN,	  diabetes,	  dyslipidemia,	  
smoking,	  family	  history,	  prior	  CHD)	  	  	  	  5	   	  	  1.075	  (1.005,	  1.149)	  	  
	  	  .035	   	  PHQ-­‐8,	  age,	  gender,	  race,	  marital	  status,	  education	  level,	  employment	  status,	  cardiac	  risk	  factors	  (HTN,	  diabetes,	  dyslipidemia,	  smoking,	  family	  history,	  prior	  CHD),	  CAS,	  PSS	  	  PHQ,	  patient	  health	  questionnaire;	  HTN,	  hypertension;	  CHD,	  coronary	  heart	  disease;	  CAS,	  clinical	  anxiety	  scale;	  PSS,	  perceived	  stress	  scale.	  Statistical	  significance	  at	  p<	  .05	  and	  95%	  CI,	  Confidence	  Interval.	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Secondary	  aim	  1:	  Depressive	  symptom	  burden,	  recurrent/persistent	  chest	  pain	  and	  gender	  As	  shown	  in	  Table	  1,	  the	  depressive	  symptom	  burden	  was	  higher	  in	  women	  with	  recurrent/persistent	  chest	  pain	  across	  all	  measures,	  compared	  to	  men.	  In	  general,	  women	  had	  higher	  rates	  of	  recurrent/persistent	  chest	  pain	  (n=74/184;	  40.2%)	  than	  men	  (n=41/143;	  28.7%).	  Mean	  PHQ-­‐8	  scores	  were	  higher	  for	  both	  men	  and	  women	  with	  recurrent/persistent	  chest	  pain	  compared	  to	  those	  without,	  however	  this	  was	  only	  statistically	  significant	  for	  women.	  Comparing	  women	  with	  recurrent/persistent	  chest	  pain	  to	  those	  without	  revealed	  a	  significant	  upward	  shift	  in	  levels	  of	  depressive	  symptom	  severity.	  For	  men	  with	  recurrent/persistent	  chest	  pain	  this	  shift	  was	  not	  consistent	  across	  levels	  of	  PHQ-­‐8	  depression,	  and	  strangely	  there	  were	  fewer	  than	  expected	  with	  moderate	  level	  depression	  scores	  (4.9%,	  N=2/41).	  The	  rate	  of	  currently	  treated	  depression	  was	  higher	  for	  both	  men	  and	  women	  with	  recurrent/persistent	  chest	  pain	  versus	  those	  without,	  but	  the	  numbers	  were	  small	  for	  men.	  Of	  both	  men	  and	  women	  using	  antidepressants,	  more	  than	  40%	  had	  recurrent/persistent	  chest	  pain	  (6/13	  men	  and	  19/41	  women).	  The	  overall	  burden	  of	  depression	  was	  highest	  among	  women	  with	  recurrent/persistent	  chest	  pain	  (43.2%),	  and	  differed	  significantly	  from	  women	  without	  recurrent/persistent	  chest	  pain	  (26.4%),	  (χ2(1,	  N=184)=5.17,	  p=	  .023).	  In	  contrast,	  men	  with	  and	  without	  recurrent/persistent	  chest	  pain	  had	  more	  similar	  rates	  of	  burden	  of	  depression	  (26.8%	  vs.	  22.5%,	  respectively),	  and	  no	  statistical	  different	  was	  present	  (χ2(1,	  N=143)=0.296,	  p=	  .587).	  Interestingly,	  our	  study	  revealed	  an	  equal	  number	  of	  men	  and	  women	  with	  unrecognized	  depression.	  However,	  the	  majority	  of	  these	  women	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went	  on	  to	  have	  recurrent	  chest	  pain	  (12	  out	  of	  20	  (60%)),	  compared	  to	  men	  (5	  out	  of	  21	  (24%)).	  	  The	  correlation	  between	  depressive	  symptom	  severity	  and	  frequency	  of	  chest	  pain	  was	  strongest	  in	  women,	  and	  Spearman	  analysis	  showed	  a	  significant	  fairly	  positive	  result	  (rs=0.355,	  n=184,	  p=	  .000).	  The	  same	  relationship	  was	  evident	  for	  cognitive	  symptoms	  (rs=0.286,	  n=179,	  p=	  .000),	  and	  to	  a	  slightly	  greater	  extent,	  somatic	  symptoms	  (rs=0.311,	  n=179,	  p=	  .000).	  In	  contrast,	  Spearman	  analysis	  of	  men’s	  depression	  scores	  and	  symptom	  frequency	  produced	  very	  low	  strength	  relationships,	  and	  did	  not	  achieve	  statistical	  significance.	  Gender	  also	  had	  a	  significant	  effect	  on	  recurrent	  chest	  pain	  in	  all	  models	  shown	  in	  Table	  3.,	  where	  included	  (model	  5:	  female-­‐weighted	  OR=	  1.717;	  95%	  CI=	  1.041,	  2.831;	  p=	  .034),	  indicating	  women	  to	  have	  seventy	  one	  percent	  higher	  odds	  of	  having	  recurrent/persistent	  chest	  pain	  compared	  to	  men	  while	  adjusting	  for	  socio-­‐demographic,	  clinical	  and	  psychological	  factors.	  	  	  Missing	  data	  	  About	  one	  fourth	  of	  enrolled	  patients	  were	  lost	  to	  follow-­‐up	  (n=108).	  These	  patients	  were	  compared	  to	  the	  analytic	  sample,	  to	  account	  for	  potential	  disparities,	  as	  shown	  in	  Table	  4.	  No	  meaningful	  differences	  were	  observed	  for	  baseline	  demographic	  information,	  including	  age,	  gender	  and	  race.	  Interestingly,	  the	  group	  lost	  to	  follow-­‐up	  had	  a	  higher	  rate	  of	  PHQ-­‐8	  scores	  ≥10	  (26.9%	  vs.	  19.6%),	  indicating	  a	  potential	  loss	  of	  depressed	  patients.	  This	  loss	  was	  evident	  for	  both	  genders,	  and	  particularly	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pronounced	  for	  men,	  with	  a	  28.3%	  rate	  of	  depression	  among	  men	  lost	  to	  follow-­‐up,	  compared	  to	  18.2%	  of	  men	  in	  the	  analytic	  sample.	  Also	  contributing	  to	  missing	  data:	  seven	  patients	  who	  had	  not	  properly	  completed	  the	  PHQ-­‐8	  survey	  were	  excluded	  from	  the	  overall	  analysis,	  and	  six	  patients	  with	  absent	  hard-­‐copy	  (itemized)	  PHQ-­‐8	  data	  were	  excluded	  from	  the	  cognitive/somatic	  symptom	  portion	  of	  the	  analysis.	  	  	  	  	   Table	  4.	  Characterization	  and	  comparison	  between	  patients	  lost	  to	  follow-­‐up	  and	  analytic	  sample.	  	  	   	  
Lost	  to	  Follow	  Up	  
(n	  =	  108)	   Patients	  that	  Completed	  Follow	  Up	  




	  This	  is	  the	  first	  U.S.	  based	  ED	  study	  to	  show	  that	  depressive	  symptoms	  in	  the	  emergency	  department	  patients	  predict	  recurrence	  of	  chest	  pain.	  We	  report	  three	  key	  findings.	  First,	  we	  demonstrated	  a	  high	  prevalence	  of	  depression	  in	  our	  low-­‐risk	  cardiac	  observation	  unit	  population.	  Second,	  we	  found	  that	  depression	  was	  independently	  associated	  with	  recurrent	  chest	  pain	  post-­‐discharge.	  And	  finally,	  these	  effects	  preferentially	  impacted	  women	  as	  opposed	  to	  men.	  	  We	  found	  that	  about	  30%	  of	  low-­‐risk	  ED	  cardiac	  observation	  patients	  screened	  positive	  for	  depression,	  and	  12.5%	  received	  this	  as	  a	  new	  diagnosis.	  These	  figures	  likely	  underestimate	  the	  true	  burden	  of	  depression,	  yet	  are	  comparable	  to	  the	  20-­‐25%	  in	  post-­‐MI	  patients,	  and	  far	  surpass	  depression	  in	  the	  general	  population.	  This	  is	  also	  consistent	  with	  our	  prior	  report	  from	  five	  years	  ago	  that	  demonstrated	  similar	  high	  rates	  of	  depression	  using	  a	  different	  screening	  tool	  in	  the	  ED	  chest	  pain	  population.	  According	  to	  a	  2009-­‐2012	  CDC	  household	  report,	  9.8%	  of	  Americans	  aged	  40-­‐59	  were	  moderately	  to	  severely	  depressed.36	  An	  important	  clinical	  reminder,	  the	  CDC	  found	  the	  most	  depression	  occurs	  in	  the	  40-­‐59	  age	  group,	  which	  corresponds	  with	  the	  demographics	  of	  our	  study	  population.36	  Existing	  literature	  on	  depression	  in	  low-­‐risk	  ED	  cardiac	  observation	  units	  is	  limited,	  has	  produced	  conflicting	  findings,	  and	  has	  been	  conducted	  mostly	  outside	  the	  US.	  Here	  in	  the	  US,	  depression	  in	  non-­‐cardiac	  chest	  pain	  is	  primarily	  studied	  in	  primary	  care	  settings,	  and	  a	  paucity	  of	  these	  studies	  in	  acute	  care	  settings	  may	  reflect	  a	  lost	  opportunity	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for	  preventative	  care.	  The	  rates	  in	  our	  study	  are	  consistent	  with	  a	  2011	  BMJ	  systematic	  review	  of	  psychological	  outcomes	  in	  patients	  with	  acute	  non-­‐cardiac	  chest	  pain,	  that	  found	  the	  prevalence	  of	  probable	  depression	  from	  9%	  to	  40%.6	  A	  Turkish	  study	  of	  similar	  size	  to	  our	  study,	  found	  more	  than	  half	  of	  ED	  patients	  with	  chest	  pain	  to	  be	  depressed,	  regardless	  of	  the	  cause	  of	  the	  chest	  pain.9	  However,	  this	  study	  used	  the	  Hospital	  Anxiety	  and	  Depression	  Scale	  (HADS)	  with	  cut-­‐off	  scores	  validated	  in	  Turkey,	  making	  it	  difficult	  to	  compare	  with	  our	  methods.	  A	  much	  lower	  prevalence	  of	  depression	  (less	  than	  10%)	  was	  found	  among	  ED	  chest	  pain	  patients	  in	  an	  Australian	  study.37	  Yet	  another	  study	  done	  in	  the	  UK	  -­‐and	  more	  similar	  to	  ours	  in	  its	  CPU	  setting-­‐	  found	  a	  13%	  prevalence	  of	  depression,	  but	  noted	  this	  to	  be	  lower	  than	  the	  25%	  reported	  in	  previous	  UK	  studies.38	  The	  lack	  of	  literature	  produced	  in	  US	  ED	  settings	  and	  the	  wide	  variability	  produced	  in	  other	  countries,	  leaves	  little	  for	  comparison	  to	  our	  current	  findings	  of	  prevalence	  of	  depression.	  This	  underscores	  the	  importance	  of	  the	  present	  study	  to	  the	  body	  of	  US-­‐based,	  ED-­‐based	  inquiries.	  	  We	  considered	  the	  effect	  of	  depressive	  symptoms	  on	  recurrence	  of	  chest	  pain	  and	  found	  there	  to	  be	  small,	  but	  significant	  effect.	  Patients	  with	  recurrent/persistent	  chest	  pain	  tended	  to	  be	  younger,	  female,	  divorced,	  and	  non-­‐white	  than	  their	  counterparts	  without	  recurrent/persistent	  chest	  pain.	  Prospective	  studies	  tracking	  continued	  chest	  pain	  in	  ED	  patients	  are	  scarce.	  Our	  study	  confirms	  the	  findings	  of	  a	  UK	  based	  report	  that	  showed	  almost	  half	  of	  patients	  to	  have	  recurrent	  chest	  pain.16	  Similar	  to	  our	  findings,	  they	  found	  baseline	  depression	  to	  correlate	  with	  the	  frequency	  of	  recurrent	  chest	  pain.16	  However,	  although	  we	  found	  a	  striking	  amount	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Published	  literature	  has	  pointed	  to	  a	  distinct	  association	  between	  baseline	  somatic	  symptoms	  of	  depression	  and	  cardiovascular	  mortality	  post-­‐MI	  in	  women.21,22	  This	  lead	  us	  to	  hypothesize	  that	  the	  link	  between	  somatic	  symptoms	  and	  the	  heart	  may	  also	  be	  relevant	  to	  undifferentiated	  chest	  pain	  in	  women.	  Unexpectedly,	  we	  found	  both	  cognitive	  and	  somatic	  symptom	  dimensions	  to	  contribute	  to	  the	  relationship	  between	  PHQ-­‐8	  scores	  and	  recurrent/persistent	  chest	  pain	  in	  women,	  suggesting	  that	  cognitive	  symptoms	  also	  play	  an	  important	  role.	  	  	  	  The	  findings	  of	  this	  study,	  beg	  a	  mechanistic	  explanation	  for	  the	  link	  between	  symptoms	  of	  depression	  and	  symptoms	  of	  the	  heart.	  Most	  of	  the	  work	  in	  this	  general	  area	  has	  been	  done	  in	  depressed	  patients	  post-­‐MI,	  as	  we	  know	  that	  depression	  predicts	  poor	  cardiac	  outcomes	  in	  this	  group,	  and	  also	  predicts	  a	  higher	  likelihood	  of	  having	  recurrent	  chest	  pain	  in	  the	  first	  six	  months	  post-­‐MI.42	  Theories	  fall	  into	  two	  major	  camps:	  biologic	  and	  behavioral.	  Possible	  biological	  links	  can	  be	  divided	  into	  autonomic	  dysfunction	  (reduced	  heart	  rate	  variability	  and	  baroreceptor	  sensitivity),	  neuroendocrine	  activation	  (hypothalamic-­‐pituitary	  axis	  dysfunction)	  and	  inflammatory	  responses.	  Behavioral	  theory	  considers	  depression’s	  association	  with	  risk	  factors	  such	  as	  smoking,	  obesity,	  sedentary	  lifestyle	  and	  medication	  non-­‐compliance,	  to	  be	  indirectly	  driving	  the	  link	  to	  heart	  disease.	  It	  is	  also	  possible	  that	  depression	  could	  increase	  the	  risk	  of	  microvascular	  disease	  in	  these	  patients	  and	  the	  recurrence	  of	  pain	  is	  from	  microvascular	  angina	  as	  opposed	  to	  obstructive	  angina.	  In	  the	  absence	  of	  widely	  available	  screening	  tests	  for	  microvascular	  disease,	  this	  mechanism	  still	  needs	  to	  be	  investigated.	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  The	  comorbidity	  of	  depression	  and	  chronic	  chest	  pain	  has	  been	  long	  recognized	  by	  the	  primary	  care	  community.	  Even	  in	  the	  absence	  of	  a	  proven	  mechanism	  to	  explain	  the	  link	  between	  depression	  and	  chest	  pain,	  treatments	  have	  been	  targeted	  at	  the	  interaction.	  Particularly,	  therapies	  that	  promote	  neuroplasticity	  may	  be	  most	  useful.	  Although	  few	  randomized	  controlled	  trials	  exist,	  cognitive	  behavioral	  therapy	  (CBT)	  appears	  to	  be	  the	  most	  effective	  psychological	  therapy	  at	  diminishing	  chest	  pain.43	  For	  example,	  in	  a	  1999	  Netherlands	  study,	  CBT	  treatment	  was	  found	  to	  improve	  chest	  pain	  in	  48-­‐50%	  of	  patients	  receiving	  up	  to	  twelve	  CBT	  sessions,	  compared	  to	  6-­‐13%	  of	  those	  receiving	  standard	  care.44	  Hypnotherapy	  also	  appeared	  to	  have	  marked	  benefit	  in	  decreasing	  non-­‐cardiac	  chest	  pain,	  as	  shown	  in	  a	  very	  small	  but	  significant	  2006	  trial.45	  Systematic	  review	  of	  medication	  trials	  has	  suggested	  modest	  evidence	  that	  low-­‐dose	  antidepressants	  benefit	  NCCP	  by	  reducing	  symptoms.46	  Interestingly,	  the	  five	  studies	  that	  assessed	  depression	  found	  scores	  were	  stable	  over	  time,	  suggesting	  that	  the	  pain-­‐modulating	  effects	  of	  the	  antidepressants	  is	  distinct	  from	  the	  measured	  symptoms	  of	  depression.46	  However,	  the	  small	  number	  and	  heterogeneity	  of	  the	  existing	  works	  limits	  the	  drawing	  of	  comprehensive	  conclusions	  and	  warrants	  more	  rigorous	  trials.	  	  	  Our	  interest	  in	  the	  prospect	  of	  cognitive/somatic	  symptoms	  dimensions	  in	  patients	  with	  chest	  pain	  was	  partly	  inspired	  by	  findings	  of	  the	  Enhancing	  Recovery	  In	  Coronary	  Heart	  Disease	  (ENRICHD)	  study.	  This	  work	  with	  post-­‐MI	  patients	  found	  treatment	  with	  CBT	  +/-­‐	  sertraline	  to	  decrease	  cognitive	  and	  somatic	  symptoms	  of	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depression,	  but	  found	  only	  the	  decreases	  in	  somatic	  symptoms	  to	  be	  associated	  with	  improved	  cardiac	  prognosis.47	  In	  contrast,	  we	  found	  both	  somatic	  and	  cognitive	  symptoms	  to	  be	  similarly	  associated	  with	  the	  recurrence/persistence	  of	  chest	  pain,	  suggesting	  that	  future	  research	  and/or	  treatment	  of	  pain	  and	  associated	  depression	  may	  not	  benefit	  from	  targeting	  of	  symptom	  dimensions	  of	  depression.	  	  	  This	  study	  had	  several	  limitations.	  For	  starters,	  the	  original	  design	  of	  the	  study	  was	  intended	  to	  assess	  perceived	  stress,	  and	  the	  sample	  population	  was	  powered	  for	  those	  conditions.	  Also,	  the	  interim	  analysis	  reported	  here	  was	  run	  prior	  to	  achievement	  of	  the	  enrollment	  goal,	  in	  order	  to	  make	  this	  thesis	  deadline.	  However,	  we	  scrutinized	  all	  of	  our	  analyses	  for	  statistical	  significance,	  and	  selected	  tests	  that	  were	  appropriate	  for	  our	  sample	  size.	  We	  intend	  to	  use	  the	  same	  aim	  and	  analytical	  techniques	  upon	  completion	  of	  the	  study.	  	  Missing	  data,	  primarily	  related	  to	  our	  follow-­‐up	  rate,	  was	  a	  key	  weakness	  of	  this	  study.	  We	  made	  concerted	  efforts	  to	  complete	  follow-­‐ups,	  however	  during	  the	  study	  there	  were	  random	  periods	  when	  the	  research	  team	  was	  not	  available	  for	  telephone	  follow-­‐ups.	  This	  can	  potentially	  introduce	  random	  bias.	  For	  example,	  we	  know	  that	  there	  was	  a	  preferential	  loss	  of	  depressed	  patients,	  and	  depressed	  men	  in	  particular.	  We	  acknowledge	  that	  the	  addition	  of	  these	  cases	  would	  have	  strengthened	  our	  sample	  size	  and	  could	  have	  potentially	  rendered	  statistical	  significance	  to	  our	  findings	  for	  men.	  Fortunately,	  we	  suspect	  that	  completion	  of	  these	  follow-­‐ups	  would	  most	  likely	  strengthen	  our	  findings,	  and	  not	  the	  opposite	  given	  the	  positive	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relationship	  between	  depression	  and	  recurrent	  chest	  pain.	  Upon	  completion	  of	  our	  study,	  we	  also	  intend	  to	  do	  chart	  reviews	  for	  patients	  who	  did	  not	  complete	  follow-­‐up.	  	  Due	  to	  our	  inability	  to	  accommodate	  languages	  other	  than	  English,	  we	  lost	  a	  large	  number	  of	  Spanish	  speakers.	  This	  makes	  the	  application	  of	  our	  findings	  to	  the	  Hispanic	  population	  a	  challenge.	  This	  is	  particularly	  important	  as	  our	  demographic	  data	  suggested	  that	  recurrent	  chest	  pain	  was	  more	  common	  among	  Blacks	  and	  Hispanics,	  compared	  to	  Caucasians,	  and	  our	  numbers	  may	  actually	  underestimate	  the	  burden	  of	  this	  disease	  in	  the	  CPC	  population.	  Future	  studies	  in	  these	  groups	  may	  be	  warranted.	  	  Additional	  limitations	  may	  stem	  from	  our	  assessment	  of	  depression.	  For	  example,	  we	  used	  the	  PHQ-­‐8	  as	  a	  screen	  for	  depression,	  which	  is	  less	  specific	  than	  interview-­‐based	  DSM-­‐based	  clinical	  diagnosis.	  Also,	  the	  PHQ-­‐8	  is	  not	  as	  commonly	  used	  in	  comparable	  international	  research	  as	  is	  the	  Hospital	  Anxiety	  and	  Depression	  Scale	  (HADS).	  While	  this	  does	  not	  invalidate	  our	  findings,	  it	  may	  make	  them	  more	  difficult	  to	  relate	  to	  the	  study	  designs,	  methods	  and	  results	  of	  the	  existing	  body	  of	  literature.	  Also,	  we	  assessed	  baseline	  symptoms	  of	  depression	  and	  did	  not	  reassess	  on	  follow-­‐up,	  but	  it	  may	  be	  worthwhile	  for	  future	  studies	  to	  compare	  trends	  in	  depression	  scores	  to	  trends	  in	  chest	  pain,	  in	  the	  absence	  or	  presence	  of	  treatment.	  Moreover,	  we	  did	  not	  query	  patients,	  or	  obtain	  collateral,	  on	  the	  psychiatric	  diagnoses	  they	  carried	  or	  non-­‐pharmacologic	  treatments	  they	  may	  have	  been	  receiving	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  Our	  study	  confirms	  a	  high	  prevalence	  of	  depression	  in	  ED	  patients	  with	  chest	  pain,	  and	  suggests	  a	  relationship	  between	  depression	  and	  recurrence	  of	  chest	  pain,	  particularly	  for	  women.	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